azomycin has been researched along with mebendazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Engel, C; Hengstmann, JH; Lindecken, KD; Schulz, D; Siedek, M | 1 |
| Brito, K; Cañete, R; Herrera, E; Kofoed, PE; Noda, AL; Rodríguez, M; Ursing, J | 1 |
| Hanevik, K; Mørch, K | 1 |
1 review(s) available for azomycin and mebendazole
| Article | Year |
|---|---|
Giardiasis treatment: an update with a focus on refractory disease.
Topics: Adult; Albendazole; Antiprotozoal Agents; Benzimidazoles; Child; Diarrhea; Drug Resistance; Drug Therapy, Combination; Female; Giardia; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Nitroimidazoles; Quinacrine | 2020 |
2 other study(ies) available for azomycin and mebendazole
| Article | Year |
|---|---|
[Possibilities of surgical and drug therapy of parasitic cholestasis].
Topics: Amebiasis; Cholestasis; Combined Modality Therapy; Echinococcosis, Hepatic; Humans; Liver Abscess; Mebendazole; Nitroimidazoles; Opisthorchiasis; Praziquantel; Ultrasonography | 1985 |
5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
Topics: Adult; Aged; Antiprotozoal Agents; Cuba; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Feces; Female; Giardia lamblia; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Middle Aged; Nitroimidazoles; Prospective Studies; Quinacrine; Treatment Outcome; Young Adult | 2020 |